IMPACT Therapeutics, Inc (07630)
Founded in 2009, Inpai Pharmaceutical is a commercialized biotechnology company committed to promoting precise anti-cancer therapies based on synthetic lethal mechanisms globally and creating innovative therapies to meet the unmet medical needs of cancer patients. The company has established one of the most comprehensive and advanced synthetic lethal product portfolios through independent research and development.
CS Hotline: +852 3018 4526
Trading days: 24 hours | Non-trading days: 9:00-18:00
